Honorati Masanja

In the News

Ifakara scientist explains why ending Tuberculosis requires better diagnostics

Ending tuberculosis through better diagnostics Author: Dr. Frederick Haraka, MD Yes, to end tuberculosis (TB), we need better diagnostic tools! TB is among the deadliest diseases in the world. In …

Study: 12% of people living with HIV in rural Tanzania have hypertension

Dar es Salaam, Tanzania (March 9, 2017). IHI Research Scientist Dr Kim Mwamelo presents findings of the study in Boston, US, last year at the Conference on Retroviruses and Opportunistic …

Recent Projects

Assessing the progress towards rabies elimination from Pemba Island, Tanzania

Rabies is a deadly disease endemic in dog populations across Africa. Although rabies can be eliminated through mass dog vaccination, there has been little investment in dog vaccination in Africa …

Engaging pastoralists in controlling malaria mosquitoes in their communities

The project is aimed at applying pastoralists’ knowledge to find water bodies during the dry season and accurately identify aquatic habitats that can be treated with larvicide pyriproxyfen (PPF) to …

Honorati Masanja

Chief Executive Director

Dr Honorati Masanja is the IHI Chief Executive Director.He holds a PhD in Epidemiology from the Swiss Tropical and Public Health Institute, University of Basel. He’s a statistician and epidemiologist, with an extensive experience in data management; clinical trials; design, and evaluation of large maternal and child health programs. He joined the Institute in 1992.

Over the last 25 years, he has lead the successful acquisition and implementation of national and regional projects whose direct impact on strengthening Tanzania’s health system is still seen today. Having participated in the establishment of the Rufiji Health and Demographic Surveillance System (RHDSS), Dr Masanja became the Principal Investigator for the SAVVY project, a step in Tanzania’s shift towards evidence-based planning and enabling health-sector evaluation.

Currently, he is the PI of the AMANHI study where, alongside with colleagues, he is leading innovative research on maternal and newborn health by critically evaluating the impact of the Vitamin A supplementation trial.

Dr Masanja’s scientific engagement spans across borders. Having published extensively in international journals and books, he is also an editorial reviewer for the MRC Joint Health Systems Research Initiative, and member of Tanzania’s National eHealth Steering Committee and the Steering Committee for Monitoring and Evaluation.

His experience in training Post-Doctoral, Doctoral and Masters students in Tanzania lead to his 2013 appointment as an Adjunct Professor in the School of Life Sciences of the Nelson Mandela African Institute for Science and Technology.

View Dr. Masanja’s Research Interests and Publications

Projects

Measuring the useful life of bed nets for malaria control in Tanzania: attrition, bioefficacy, chemistry, durability and insecticide resistance

Zoonotic viral sharing among bats, primates and people in high-risk areas in Tanzania

Using a safe-delivery mobile application to improve care for mothers and newborns

Data for Health Initiative: using data to inform decisions on critical public health policies in Tanzania

Homestead agriculture for improving the nutrition and health of children and women in rural Tanzania

A PIXELBASE DESIGN
© Ifakara Health Institute (IHI), 2016